|By Business Wire||
|August 18, 2014 12:40 PM EDT||
Research and Markets (http://www.researchandmarkets.com/research/53xwbk/global) has announced the addition of the "Global Regenerative Medicines Market (Technology, Application and Geography) - Size, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering.
According to a new market research report titled, "Global Regenerative Medicine Market (Technology, Applications, Geography) - Industry Analysis, Trends, Opportunities and Forecast, 2013-2020", the global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during forecast period (2014 - 2020). Small molecules and biologics segment holds prominent market share in the overall regenerative medicine technology market and is anticipated to grow at a CAGR of 18.9% during the forecast period.
Regenerative medicines have the ability to restore the lost functionality of tissues or organs, unlike conventional medicines, which are palliative. The immense potential of these medicines in repairing or regenerating diseased organs is the major reason for intensive focus on research and development in this field. The technologies implemented for these medicines utilize various cell types including stem cells. The advancements in nanotechnology and stem cells application would account for further progress of this novel field of medicine. The global regenerative medicine market is segmented based on technologies into small molecules and biologics, gene therapy and cell therapy.
Key Topics Covered:
CHAPTER 1. INTRODUCTION
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. GLOBAL REGENERATIVE MEDICINES MARKET OVERVIEW
CHAPTER 4. GLOBAL REGENERATIVE MEDICINE MARKET BY TECHNOLOGIES
CHAPTER 5. GLOBAL REGENERATIVE MEDICINE MARKET BY APPLICATIONS
CHAPTER 6. GLOBAL REGENERATIVE MEDICINES MARKET BY GEOGRAPHY
CHAPTER 7. COMPANY PROFILES
- Advanced Cell Technology
- Athersys Inc.
- Cytori Therapeutics
- Kinetic Concepts
- Mesoblast Ltd.
- Shire pharmaceuticals
- Stem Cells
For more information visit http://www.researchandmarkets.com/research/53xwbk/global
Jul. 29, 2016 05:00 AM EDT Reads: 1,418
Jul. 29, 2016 04:45 AM EDT Reads: 2,560
Jul. 29, 2016 04:45 AM EDT Reads: 2,357
Jul. 29, 2016 04:30 AM EDT Reads: 1,394
Jul. 29, 2016 04:15 AM EDT Reads: 2,670
Jul. 29, 2016 03:45 AM EDT Reads: 1,036
Jul. 29, 2016 02:45 AM EDT Reads: 1,598
Jul. 29, 2016 02:30 AM EDT Reads: 1,456
Jul. 29, 2016 02:00 AM EDT Reads: 1,677
Jul. 29, 2016 12:30 AM EDT Reads: 1,700
Jul. 29, 2016 12:15 AM EDT Reads: 2,091
Jul. 29, 2016 12:15 AM EDT Reads: 1,993
Jul. 28, 2016 11:45 PM EDT Reads: 1,243
Jul. 28, 2016 10:15 PM EDT Reads: 2,228
"We've discovered that after shows 80% if leads that people get, 80% of the conversations end up on the show floor, meaning people forget about it, people forget who they talk to, people forget that there are actual business opportunities to be had here so we try to help out and keep the conversations going," explained Jeff Mesnik, Founder and President of ContentMX, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Jul. 28, 2016 10:15 PM EDT Reads: 1,444